Psychological and Behavioral Impact of Participation in Ovarian Cancer Screening

Psychological and Behavioral Impact of Participation in Ovarian Cancer Screening

Evaluation of costs and benefits associated with cancer screening should include consideration of any psychological and behavioral impact associated with screening participation. Research examining the psychological and behavioral impact of screening asymptomatic women for ovarian cancer (OC) was co...

Full description

Bibliographic Details
Main Author:	Michael A. Andrykowski
Format:	Article
Language:	English
Published:	MDPI AG 2017-03-01
Series:	Diagnostics
Subjects:	ovarian cancer psychological psychosocial behavioral screening false positive test result
Online Access:	http://www.mdpi.com/2075-4418/7/1/15

Similar Items

Psychosocial Impact of False-Positive Newborn Screening Results: A Scoping Review
by: Jane Chudleigh, et al.
Published: (2024-04-01)

Healthcare professionals' experiences of caring for women with false‐positive screening test results in the National Health Service Breast Screening Programme
by: Hannah A. Long, et al.
Published: (2024-04-01)

Optimising data sharing whilst protecting participant privacy: a data note describing processed data from a qualitative study of healthcare professionals’ experiences of caring for women with false positive screening test results
by: Hannah A. Long, et al.
Published: (2025-12-01)

False Negative Results in Cervical Cancer Screening—Risks, Reasons and Implications for Clinical Practice and Public Health
by: Anna Macios, et al.
Published: (2022-06-01)

Estimation of Population Prevalence of COVID-19 Using Imperfect Tests
by: Leonid Hanin
Published: (2020-10-01)

Past as Prologue: Predicting Potential Psychosocial–Ethical Burdens of Positive Newborn Screens as Conditions Propagate
by: Lynn W. Bush, et al.
Published: (2024-02-01)

Retraining over the principles and mechanisms involved in the occurrence of false results from urine drug screening tests: Adulteration and strategies to defeat
by: Bamdad Riahi-Zanjani
Published: (2022-12-01)

Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer—Results of a false‐negative cytology audit in Polish Cervical Cancer Screening Programme
by: Anna Macios, et al.
Published: (2023-06-01)

Clinical characteristics and cause analysis of false-positive results in treponemal testing among patients
by: Wei Wang, et al.
Published: (2025-12-01)

Psychosocial Impact of a True-Positive, False-Positive, or Inconclusive Newborn Bloodspot Screening Result: A Questionnaire Study among Parents
by: Lieke M. van den Heuvel, et al.
Published: (2024-03-01)

Enzyme immunoassay in the practice of a physician
by: Oksana V. Moskalets
Published: (2022-06-01)

False positives of screening in large-scale population with low infection rate of an infectious diseasea： a modeling analysis
by: JIANG Honglin, et al.
Published: (2022-04-01)

Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening
by: Sisse Helle Njor, et al.
Published: (2020-08-01)

EXPERIENCE OF STUDY AND POSSIBLE WAYS OF ELIMINATION OF FALSE POSITIVE AND FALSE NEGATIVE RESULTS DURING EXECUTION OF POLYMERASE CHAIN REACTION ON AN EXAMPLE OF JUNIN VIRUS RNA DETECTION
by: T. E Sizikova, et al.
Published: (2015-12-01)

Influence of screen teaching on children's psychological and behavior problems
by: CHEN Lu, ZHU Hui-juan, CHEN Shi, ZHANG Mei, BAN Bo, YANG Yan-jie, PAN Hui
Published: (2021-12-01)

Communicating a Positive Result at Newborn Screening and Parental Distress
by: Elisa Lastrucci, et al.
Published: (2023-07-01)

Predictors of re-attendance at biennial screening mammography following a false positive referral: A study among women in the south of the Netherlands
by: Adri C. Voogd, et al.
Published: (2024-04-01)

dbRUSP: An Interactive Database to Investigate Inborn Metabolic Differences for Improved Genetic Disease Screening
by: Gang Peng, et al.
Published: (2022-08-01)

Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications
by: Elena R. Beauregard, PharmD, BCPS, et al.
Published: (2024-04-01)

False positive values of biomarkers of prenatal screening on chromosomopathy as indicators of a risky pregnancy
by: Durković Jasmina, et al.
Published: (2011-01-01)

Advantages and Limitations of Ultrasound as a Screening Test for Ovarian Cancer
by: Antonios Koutras, et al.
Published: (2023-06-01)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
by: Masafumi Koshiyama, et al.
Published: (2017-03-01)

The Value of Reducing Inconclusive and False-Positive Newborn Screening Results for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia and Maple Syrup Urine Disease in The Netherlands
by: Rosalie C. Martens, et al.
Published: (2024-10-01)

Retrospective Review of Positive Newborn Screening Results for Isovaleric Acidemia and Development of a Strategy to Improve the Efficacy of Newborn Screening in the UK
by: Rachel S. Carling, et al.
Published: (2024-03-01)

Lessons from a genome-wide CRISPR-Cas9 screening: what researchers should know before start
by: Mohammad Masoudi
Published: (2021-12-01)

Hypothalamic‐pituitary‐adrenal axis recovery after intermediate‐acting glucocorticoid treatment in client‐owned dogs
by: Francesca Del Baldo, et al.
Published: (2024-03-01)

Development and research of a model for differential diagnosis of latent late syphilis and false-positive serological reactions on immunochips with a panel of 12 Treponema pallidum antigens
by: Marina V. Shpilevaya, et al.
Published: (2021-07-01)

Opioid false-positivity in urine drug screening: levomepromazine cross-reactivity
by: Nuno Rodrigues-Silva, et al.
Published: (2017-01-01)

Development of Strategies to Decrease False Positive Results in Newborn Screening
by: Sabrina Malvagia, et al.
Published: (2020-11-01)

Factors associated with false-positive screening mammography in São Paulo, Brazil
by: Alice Barros Câmara, et al.
Published: (2025-02-01)

The importance of batch sensitization in missing value imputation
by: Hui, Harvard Wai Hann, et al.
Published: (2023)

Postnatal corticosteroid treatment as a risk factor for false positivity in severe combined immunodeficiency newborn screening
by: Po-Sung Chen, et al.
Published: (2023-08-01)

Cystic Fibrosis Newborn Screening in Austria Using PAP and the Numeric Product of PAP and IRT Concentrations as Second-Tier Parameters
by: Maximilian Zeyda, et al.
Published: (2021-02-01)

Analyzing false‐negative results detected in low‐risk non‐invasive prenatal screening cases
by: Ying Lin, et al.
Published: (2020-04-01)

Psychosocial Issues Related to Newborn Screening: A Systematic Review and Synthesis
by: Audrey Tluczek, et al.
Published: (2022-09-01)

Evaluation of a two-test strategy for HIV screening in a low-prevalence setting and the indications for optimizing clinical management
by: Yu Huang, et al.
Published: (2023-09-01)

LDCT screening results among eligible and ineligible screening candidates in preventive health check-ups population: a real world study in West China
by: Ting Bao, et al.
Published: (2024-02-01)

Understanding the Experience of Canadian Women Living with Ovarian Cancer through the Every Woman Study<sup>TM</sup>
by: Alicia Tone, et al.
Published: (2022-05-01)

Psychosocial Screening in Adult Burns Inpatients within a Scottish Burns Unit
by: Dawn Lindsay, et al.
Published: (2023-05-01)

Ovarian cancer prevention and screening – where do we stand today?
by: Cristina Bucur, et al.
Published: (2024-04-01)